Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DYW34G
|
|||
| Drug Name |
JCell
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Retinitis pigmentosa [ICD-11: 9B70; ICD-10: H35.5] | Phase 2 | [1] | |
| Company |
jCyte
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04604899) A Phase 2 Study of the Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.